Insider · CIK 0001959325
Thomas Joeseph Carrico
Files at NRXS (Neuraxis, INC). First filing Apr 3, 2026, latest Oct 8, 2026.
In brief
Thomas Joeseph Carrico files SEC Form 4 as officer at NRXS (Neuraxis, INC). Since Apr 3, 2026, Thomas Joeseph Carrico has reported 2 open-market buys worth $2,895 and 0 open-market sells worth $0, the latest filed on Oct 8, 2026.
A track record needs three past buys with six months of prices behind them; Thomas Joeseph Carrico has 0, so none is measured yet.
The newest scored trade: bought $1,588 of NRXS on Oct 8, 2026, filed Oct 8, 2026, scored 25 (weak). In the last 12 months: 2 buys worth $2,895 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NRXS: Neuraxis, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Neuraxis, INC | $1,588 328 shares | +0% | - | |
| 25Weak | Neuraxis, INC | $1,307 667 shares | +0% | +349% from low-6% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | NRXS Neuraxis, INC | POpen-market purchase Common Stock | +328 | $4.84 | $1,588 | 199,673 | 6 d ago |
| Aug 24, 2026 | NRXS Neuraxis, INC | AGrant or award Common Stock | +193,678 | - | - | 199,345 | Aug 26, 2026 |
| Aug 24, 2026 | NRXS Neuraxis, INC | CConversion Stock Optionsderivative | -306,236 | $6.94 | $2.1M | 0 | Aug 26, 2026 |
| Aug 24, 2026 | NRXS Neuraxis, INC | AGrant or award RSUderivative | +306,236 | - | - | 306,236 | Aug 26, 2026 |
| Aug 24, 2026 | NRXS Neuraxis, INC | CConversion RSUderivative | -306,236 | - | - | 0 | Aug 26, 2026 |
| Aug 13, 2026 | NRXS Neuraxis, INC | AGrant or award RSUderivative | +135,906 | $6.28 | $853k | 135,906 | Aug 17, 2026 |
| Apr 1, 2026 | NRXS Neuraxis, INC | POpen-market purchase Common Stock | +667 | $1.96 | $1,307 | 331,903 | Apr 3, 2026 |
| Jan 22, 2026 | NRXS Neuraxis, INC | AGrant or award RSUderivative | +47,569 | $4.63 | $220k | 47,569 | Feb 26, 2026 |
| Mar 4, 2025 | NRXS Neuraxis, INC | AGrant or award RSUderivative | +10,000 | $2.18 | $22k | 10,000 | Sep 10, 2025 |
| Mar 4, 2025 | NRXS Neuraxis, INC | AGrant or award RSUderivative | +27,435 | $2.18 | $60k | 27,435 | Sep 10, 2025 |
| Jan 3, 2025 | NRXS Neuraxis, INC | AGrant or award RSUderivative | +35,000 | $2.42 | $85k | 35,000 | Sep 10, 2025 |
Questions about Thomas Joeseph Carrico
Answered from the filings on this page, as of the latest one.
Is Thomas Joeseph Carrico buying or selling?
In the last 12 months Thomas Joeseph Carrico reported 2 open-market buys worth $2,895 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1,588 of NRXS on Oct 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Thomas Joeseph Carrico's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Joeseph Carrico has 0.
Where does Thomas Joeseph Carrico file Form 4?
Thomas Joeseph Carrico has filed Form 4 at NRXS (Neuraxis, INC) as CRO, CCO, CPO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.